CLINICAL_TRIALS
trial_result
· 2017-03-03
Clinical Trial Update: TAilored Post-Surgical Therapy in Early Stage NSCLC [Phase 2, Phase 3]
Summary
Phase 2/3 trial evaluating tailored post-surgical therapy for early-stage non-small cell lung cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Intergroupe Francophone de Cancerologie Thoracique | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2, Phase 3 | Status: COMPLETED